| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1152995
[patent_doc_number] => 06767893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-27
[patent_title] => 'Method of treating conditions associated with intestinal ischemia/reperfusion'
[patent_app_type] => B2
[patent_app_number] => 09/416828
[patent_app_country] => US
[patent_app_date] => 1999-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 11
[patent_no_of_words] => 3830
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/767/06767893.pdf
[firstpage_image] =>[orig_patent_app_number] => 09416828
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416828 | Method of treating conditions associated with intestinal ischemia/reperfusion | Oct 11, 1999 | Issued |
Array
(
[id] => 1433378
[patent_doc_number] => 06340668
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-22
[patent_title] => 'Neuronal uses of BMP-11'
[patent_app_type] => B1
[patent_app_number] => 09/414234
[patent_app_country] => US
[patent_app_date] => 1999-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16665
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/340/06340668.pdf
[firstpage_image] =>[orig_patent_app_number] => 09414234
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414234 | Neuronal uses of BMP-11 | Oct 6, 1999 | Issued |
Array
(
[id] => 630437
[patent_doc_number] => 07132397
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-11-07
[patent_title] => 'Bone morphogenetic protein antagonist based on the mature protein'
[patent_app_type] => utility
[patent_app_number] => 09/806368
[patent_app_country] => US
[patent_app_date] => 1999-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7404
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/132/07132397.pdf
[firstpage_image] =>[orig_patent_app_number] => 09806368
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/806368 | Bone morphogenetic protein antagonist based on the mature protein | Oct 3, 1999 | Issued |
Array
(
[id] => 1298790
[patent_doc_number] => 06627729
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-30
[patent_title] => 'TML peptides'
[patent_app_type] => B1
[patent_app_number] => 09/404417
[patent_app_country] => US
[patent_app_date] => 1999-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19528
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627729.pdf
[firstpage_image] =>[orig_patent_app_number] => 09404417
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/404417 | TML peptides | Sep 22, 1999 | Issued |
| 09/355551 | FREEZE-DRIED COMPOSITION OF BONE MORPHOGENETIC PROTEIN HUMAN MP52 | Sep 20, 1999 | Abandoned |
| 09/397846 | MAMMALIAN TRANSFORMING GROWTH FACTOR BETA - 9 | Sep 16, 1999 | Abandoned |
Array
(
[id] => 1349772
[patent_doc_number] => 06579972
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-17
[patent_title] => 'Extracellular signal-regulated kinase, sequences, and methods of production and use'
[patent_app_type] => B1
[patent_app_number] => 09/393212
[patent_app_country] => US
[patent_app_date] => 1999-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30345
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/579/06579972.pdf
[firstpage_image] =>[orig_patent_app_number] => 09393212
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/393212 | Extracellular signal-regulated kinase, sequences, and methods of production and use | Sep 8, 1999 | Issued |
Array
(
[id] => 1156250
[patent_doc_number] => 06764994
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-20
[patent_title] => 'Growth/differential factor of the TGF-B family'
[patent_app_type] => B1
[patent_app_number] => 09/386450
[patent_app_country] => US
[patent_app_date] => 1999-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 11266
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/764/06764994.pdf
[firstpage_image] =>[orig_patent_app_number] => 09386450
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/386450 | Growth/differential factor of the TGF-B family | Aug 30, 1999 | Issued |
| 09/378667 | STEM CELL MAINTENANCE FACTOR MATERIALS AND METHODS | Aug 19, 1999 | Abandoned |
Array
(
[id] => 1073883
[patent_doc_number] => 06838548
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-04
[patent_title] => 'Artiodactyl epimorphine'
[patent_app_type] => utility
[patent_app_number] => 09/744989
[patent_app_country] => US
[patent_app_date] => 1999-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5528
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838548.pdf
[firstpage_image] =>[orig_patent_app_number] => 09744989
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/744989 | Artiodactyl epimorphine | Aug 19, 1999 | Issued |
| 09/375333 | MODIFIED TGF-BETA SUPERFAMILY PROTEINS | Aug 15, 1999 | Abandoned |
Array
(
[id] => 1520469
[patent_doc_number] => 06413729
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Peptidoglycan recognition proteins and their production'
[patent_app_type] => B1
[patent_app_number] => 09/374678
[patent_app_country] => US
[patent_app_date] => 1999-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12989
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413729.pdf
[firstpage_image] =>[orig_patent_app_number] => 09374678
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/374678 | Peptidoglycan recognition proteins and their production | Aug 15, 1999 | Issued |
| 09/373828 | SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF PSORIATIC ARTHRITIS | Aug 12, 1999 | Abandoned |
| 09/369643 | MAMMALIAN CYTOKINES;RELATED REAGENTS | Aug 5, 1999 | Abandoned |
Array
(
[id] => 1554196
[patent_doc_number] => 06348571
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-19
[patent_title] => 'Corticotropin release inhibiting factor and methods of using same'
[patent_app_type] => B1
[patent_app_number] => 09/366627
[patent_app_country] => US
[patent_app_date] => 1999-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 37
[patent_no_of_words] => 22301
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/348/06348571.pdf
[firstpage_image] =>[orig_patent_app_number] => 09366627
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/366627 | Corticotropin release inhibiting factor and methods of using same | Aug 2, 1999 | Issued |
| 09/363630 | NOVEL MOLECULES OF THE TANGO-175-RELATED PROTEIN FAMILY AND USES THEREOF | Jul 28, 1999 | Abandoned |
Array
(
[id] => 1065677
[patent_doc_number] => 06846803
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-25
[patent_title] => 'Antagonists specific for the corticotropin-releasing factor receptor type 2 (CRFR2)'
[patent_app_type] => utility
[patent_app_number] => 09/744441
[patent_app_country] => US
[patent_app_date] => 1999-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11098
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/846/06846803.pdf
[firstpage_image] =>[orig_patent_app_number] => 09744441
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/744441 | Antagonists specific for the corticotropin-releasing factor receptor type 2 (CRFR2) | Jul 22, 1999 | Issued |
Array
(
[id] => 6838440
[patent_doc_number] => 20030035780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'ORTHODONTIC REMEDIES CONTAINING PTH'
[patent_app_type] => new
[patent_app_number] => 09/344382
[patent_app_country] => US
[patent_app_date] => 1999-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 5583
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20030035780.pdf
[firstpage_image] =>[orig_patent_app_number] => 09344382
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/344382 | ORTHODONTIC REMEDIES CONTAINING PTH | Jun 24, 1999 | Abandoned |
Array
(
[id] => 1348161
[patent_doc_number] => 06579850
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-17
[patent_title] => 'Polypeptide, novel DNA and novel antibody'
[patent_app_type] => B1
[patent_app_number] => 09/344510
[patent_app_country] => US
[patent_app_date] => 1999-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 47
[patent_no_of_words] => 55615
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/579/06579850.pdf
[firstpage_image] =>[orig_patent_app_number] => 09344510
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/344510 | Polypeptide, novel DNA and novel antibody | Jun 24, 1999 | Issued |
Array
(
[id] => 1570781
[patent_doc_number] => 06498243
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Epimorphin antagonist and process for producing it'
[patent_app_type] => B1
[patent_app_number] => 09/337501
[patent_app_country] => US
[patent_app_date] => 1999-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7955
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498243.pdf
[firstpage_image] =>[orig_patent_app_number] => 09337501
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/337501 | Epimorphin antagonist and process for producing it | Jun 21, 1999 | Issued |